Whitehawk Therapeutics (WHWK) Payables (2010 - 2026)

Whitehawk Therapeutics (WHWK) has 17 years of Payables data on file, last reported at $1.7 million in Q1 2026.

• Payables for Q1 2026 came in at $1.7 million, down 52.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 52.28% YoY), and the FY2025 annual result was $917000.0, down 57.53% from the prior year.
• Payables advanced to $1.7 million in Q1 2026 per WHWK's latest filing, from $917000.0 in the prior quarter.
• Over five years, Payables peaked at $6.5 million in Q1 2023 and troughed at $917000.0 in Q4 2025.
• A 5-year average of $3.1 million and a median of $3.1 million in 2024 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2024: Payables surged 774.29% in 2022, then tumbled 63.39% in 2024.
• A 5-year view of Payables shows it stood at $3.5 million in 2022, then jumped by 67.6% to $5.9 million in 2023, then plunged by 63.39% to $2.2 million in 2024, then plunged by 57.53% to $917000.0 in 2025, then surged by 90.29% to $1.7 million in 2026.
• Business Quant data shows WHWK's Payables at $1.7 million in Q1 2026, $917000.0 in Q4 2025, and $1.6 million in Q3 2025.